Cargando…

Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients

Autoimmune retinopathy (AIR) is a rare immune-mediated retinopathy associated with circulating antiretinal antibodies (ARAs). Other prominent features of AIR include visual field deficits and photoreceptor dysfunction in the setting of progressive unexplained vision loss. The role of inflammation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Detrick, Barbara, Gangaputra, Sapna, Palsgrove, Doreen N., Heaney, Christopher D., Hooks, John J., Nida Sen, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801042/
https://www.ncbi.nlm.nih.gov/pubmed/29310941
http://dx.doi.org/10.1016/j.jneuroim.2017.12.014
_version_ 1783298288627220480
author Detrick, Barbara
Gangaputra, Sapna
Palsgrove, Doreen N.
Heaney, Christopher D.
Hooks, John J.
Nida Sen, H.
author_facet Detrick, Barbara
Gangaputra, Sapna
Palsgrove, Doreen N.
Heaney, Christopher D.
Hooks, John J.
Nida Sen, H.
author_sort Detrick, Barbara
collection PubMed
description Autoimmune retinopathy (AIR) is a rare immune-mediated retinopathy associated with circulating antiretinal antibodies (ARAs). Other prominent features of AIR include visual field deficits and photoreceptor dysfunction in the setting of progressive unexplained vision loss. The role of inflammation is poorly understood in AIR. Since cytokines play a central role in the initiation and development of inflammation, we evaluated the presence of proinflammatory cytokines and chemokines in AIR patient sera. We demonstrate that IL-6 and CXCL9 are both elevated in AIR patient sera. Moreover, the presence and concentration of these 2 molecules appear to correlate with AIR patient disease severity. This cytokine profile, IL-6 and CXCL9, has been described to participate in a variety of autoimmune and inflammatory diseases. Our study provides support for an activated inflammatory process in AIR and identifies possible mechanisms that can drive autoimmunity in this disease.
format Online
Article
Text
id pubmed-5801042
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-58010422019-03-15 Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients Detrick, Barbara Gangaputra, Sapna Palsgrove, Doreen N. Heaney, Christopher D. Hooks, John J. Nida Sen, H. J Neuroimmunol Article Autoimmune retinopathy (AIR) is a rare immune-mediated retinopathy associated with circulating antiretinal antibodies (ARAs). Other prominent features of AIR include visual field deficits and photoreceptor dysfunction in the setting of progressive unexplained vision loss. The role of inflammation is poorly understood in AIR. Since cytokines play a central role in the initiation and development of inflammation, we evaluated the presence of proinflammatory cytokines and chemokines in AIR patient sera. We demonstrate that IL-6 and CXCL9 are both elevated in AIR patient sera. Moreover, the presence and concentration of these 2 molecules appear to correlate with AIR patient disease severity. This cytokine profile, IL-6 and CXCL9, has been described to participate in a variety of autoimmune and inflammatory diseases. Our study provides support for an activated inflammatory process in AIR and identifies possible mechanisms that can drive autoimmunity in this disease. Elsevier B.V. 2018-03-15 2017-12-29 /pmc/articles/PMC5801042/ /pubmed/29310941 http://dx.doi.org/10.1016/j.jneuroim.2017.12.014 Text en © 2018 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Detrick, Barbara
Gangaputra, Sapna
Palsgrove, Doreen N.
Heaney, Christopher D.
Hooks, John J.
Nida Sen, H.
Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title_full Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title_fullStr Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title_full_unstemmed Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title_short Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients
title_sort elevated serum levels of il-6 and cxcl9 in autoimmune retinopathy (air) patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801042/
https://www.ncbi.nlm.nih.gov/pubmed/29310941
http://dx.doi.org/10.1016/j.jneuroim.2017.12.014
work_keys_str_mv AT detrickbarbara elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients
AT gangaputrasapna elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients
AT palsgrovedoreenn elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients
AT heaneychristopherd elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients
AT hooksjohnj elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients
AT nidasenh elevatedserumlevelsofil6andcxcl9inautoimmuneretinopathyairpatients